Aurisco Pharmaceutical Co.,Ltd. (SHA:605116)
China · Delayed Price · Currency is CNY 26.68
+1.66 (6.63%)
At close: Mar 27, 2026
Aurisco Pharmaceutical Market Cap
Aurisco Pharmaceutical has a market cap or net worth of 10.84 billion as of March 27, 2026. Its market cap has increased by 32.86% in one year.
Market Cap
10.84B
Enterprise Value
10.79B
Revenue
1.62B
Ranking
n/a
PE Ratio
25.10
Stock Price
26.68
Market Cap Chart
Since September 21, 2020, Aurisco Pharmaceutical's market cap has increased from 4.83B to 10.84B, an increase of 124.27%. That is a compound annual growth rate of 15.77%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 27, 2026 | 10.84B | 6.50% |
| Dec 31, 2025 | 10.18B | 18.61% |
| Dec 31, 2024 | 8.58B | -18.20% |
| Dec 29, 2023 | 10.49B | 4.58% |
| Dec 30, 2022 | 10.03B | 13.58% |
| Dec 31, 2021 | 8.83B | 38.75% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Sep 21, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Star Lake Bioscience Co., Inc.Zhaoqing Guangdong | 12.15B |
| Chengdu Olymvax Biopharmaceuticals | 12.07B |
| Beijing Hotgen Biotech | 11.74B |
| Chengdu Easton Biopharmaceuticals | 11.57B |
| InventisBio | 11.56B |
| Hualan Biological Vaccine | 11.41B |
| Jiangxi Fushine Pharmaceutical | 10.28B |
| Liaoning Chengda Biotechnology | 10.03B |